Switch to:

Intra-Cellular Therapies EV-to-EBIT

: -5.29 (As of Today)
View and export this data going back to 2013. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Intra-Cellular Therapies's Enterprise Value is $1,120.20 Mil. Intra-Cellular Therapies's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was $-211.66 Mil. Therefore, Intra-Cellular Therapies's EV-to-EBIT for today is -5.29.

NAS:ITCI' s EV-to-EBIT Range Over the Past 10 Years
Min: -31.4   Med: -5.6   Max: -0.2
Current: -5.32

-31.4
-0.2

During the past 8 years, the highest EV-to-EBIT of Intra-Cellular Therapies was -0.20. The lowest was -31.40. And the median was -5.60.

NAS:ITCI's EV-to-EBIT is ranked lower than
99.99% of the 254 Companies
in the Biotechnology industry.

( Industry Median: 34.13 vs. NAS:ITCI: -5.32 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Intra-Cellular Therapies's Enterprise Value for the quarter that ended in Sep. 2020 was $1,091.33 Mil. Intra-Cellular Therapies's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was $-211.66 Mil. Intra-Cellular Therapies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2020 was -19.39%.


Intra-Cellular Therapies EV-to-EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Intra-Cellular Therapies Annual Data
Dec12 Mar13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only -17.57 -2.31 -3.17 -1.71 -11.06

Intra-Cellular Therapies Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.16 -11.06 -3.45 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Intra-Cellular Therapies EV-to-EBIT Distribution

* The bar in red indicates where Intra-Cellular Therapies's EV-to-EBIT falls into.



Intra-Cellular Therapies EV-to-EBIT Calculation

Intra-Cellular Therapies's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1120.200/-211.663
=-5.29

Intra-Cellular Therapies's current Enterprise Value is $1,120.20 Mil.
Intra-Cellular Therapies's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was -41.769 (Dec. 2019 ) + -49.086 (Mar. 2020 ) + -64.872 (Jun. 2020 ) + -55.936 (Sep. 2020 ) = $-211.66 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Intra-Cellular Therapies  (NAS:ITCI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Intra-Cellular Therapies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2020 ) =EBIT / Enterprise Value (Q: Sep. 2020 )
=-211.663/1091.3298
=-19.39 %

Intra-Cellular Therapies's Enterprise Value for the quarter that ended in Sep. 2020 was $1,091.33 Mil.
Intra-Cellular Therapies's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was -41.769 (Dec. 2019 ) + -49.086 (Mar. 2020 ) + -64.872 (Jun. 2020 ) + -55.936 (Sep. 2020 ) = $-211.66 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Intra-Cellular Therapies EV-to-EBIT Related Terms


Intra-Cellular Therapies EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)